Roelof Rongen SEC EDGAR Filings (CIK 0001698966)

SEC EDGAR filings, ownership reports, and insider transactions for Roelof Rongen.

Business address
C/O Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster, NJ, 07921
Top holdings (ownership)
GRI
Get insider transactions for this reporting owner
Roelof Rongen has filed 8 SEC EDGAR filings since 01 Mar 2017

Latest Filings

Recent SEC filings for Roelof Rongen including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 22 Sep 2025 18 Sep 2025 001-40034
4 Open 4 document View SEC filing for 4 FORM 4 27 Aug 2025 26 Aug 2025 001-40034
4 Open 4 document View SEC filing for 4 FORM 4 14 Aug 2025 13 Aug 2025 001-40034
4 Open 4 document View SEC filing for 4 FORM 4 24 Jan 2025 23 Jan 2025 001-40034
4 Open 4 document View SEC filing for 4 FORM 4 14 Aug 2023 10 Aug 2023 001-40034
3 Open 3 document View SEC filing for 3 FORM 3 25 Apr 2023 21 Apr 2023 001-40034
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 11 Sep 2017 08 Sep 2017 001-38022
3 Open 3 document View SEC filing for 3 FORM 3 01 Mar 2017 01 Mar 2017 001-38022

About this filer

Roelof Rongen files with the SEC under CIK 0001698966. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages